A radionuclide treatment for non-melanoma skin cancer is well tolerated and effective for patients with shallow skin lesions, according to researchers.

This form of vitamin B3 is linked to reduced incidence of non-melanoma skin cancer in high-risk populations. (Getty Images) ...

Providing both the physical environment (cell-cell interactions), and the growth factor cocktail that hematological cancer cells require to thrive ... into Crown Bioscience’s expertise in 3D ...

The frequency of TI-CH and its effect on tumor evolution are unclear. We characterized CHIP and TI-CH in 421 patients with early-stage non–small ... promotion of tumor organoid growth.

However, metformin did not protect Black patients against squamous cell carcinoma specifically. “This study strengthens the evidence supporting metformin's potential as a protective agent ...

The study results confirmed that the organoid’s response to therapy mirrored the response of the actual tumor in the patient’s brain, so if the tumor-derived organoid shrank after treatment ...

Yet the most common types of skin cancer are basal and squamous cells, and they rarely spread through your body. Your treatment for non-melanoma cancers may include radiation or chemotherapy ...

Krönert MIC, Schwarzenböck SM, Kurth J, et al. Patient-orientated evaluation of treatment of non-melanoma skin cancer with rhenium-188 compared to surgery. Healthcare (Basel) . 2024;12(9):921 ...

Maryna Panamarova (left) is a Cellular Modelling Technical Specialist at the Wellcome Sanger Institute (Cambridge, UK), in the scientific operations department. The scientific operations department ...

“If a drug had no effect on the tumor organoid, then this treatment would also have no effect on the patient – and vice versa,” said Oliver Sieber, the study’s corresponding autho ...

Visit LetsGetRealAboutSkinCancer.com to learn more about non-melanoma skin cancer, including some of its features in people of color, and to take a pledge to see a dermatologist for a skin check.

To this end, a research team from Japan attempted to create cancer cell organoid systems that can effectively resemble PDAC and act as a screening tool in anticancer research. Dr. Takeuchi Kenta ...